Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipo-PGE1 in Ischemic Heart Disease with Diabetes Mellitus
NCT03159559Phase 4Unknown
- Sponsor
- Tongji Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2017
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
A Phase 4 trial of lipo-prostaglandin E1 in ischemic heart disease (IHD), sponsored by Tongji Hospital. Status: unknown.
02
Drugs
lipo-prostaglandin E1
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT03159559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03159559.